Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of 0.05% cyclosporine ophthalmic emulsion (Restasis® , Allergan)
versus an artificial tears alone in patients with meibomian gland dysfunction that have
abnormal tear quality and quantity by subjective symptoms and signs including tear breakup
time